Membrane raft-localized EGFR expression is altered in MCF-7 and MDA-MB-231 cells by cholesterol metabolite 4-cholesten-3-one, which decreases breast cancer cell viability, reduces lipogenesis, and enhances liver X receptor-dependent cholesterol transporters [54]. The gene discussed is EGFR; the disease is breast carcinoma.